In Silico Design of Protein Kinase Inhibitors: Successes and Failures
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
171-188
Author(s):
Galina G. Dubinina, Oleksandr O. Chupryna, Maxim O. Platonov, Petro O. Borisko, Galina V. Ostrovska, Andriy O. Tolmachov and Alexander A. Shtil
Recent Progress in Discovery and Development of Antimitotic Agents
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
189-208
Author(s):
Alex Kiselyov, Konstantin V. Balakin, Sergey E. Tkachenko, Nikolay Savchuk and Alexandre V. Ivachtchenko
Antitumor Carbazoles
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
247-267
Author(s):
Christian Asche and Martine Demeunynck
Clinical Trials with Oncolytic Adenovirus in China
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
141-148
Author(s):
Wang Yu and Hu Fang
Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
157-167
Author(s):
Robert M. Lorence, M. Scot Roberts, James D. O'Neil, William S. Groene, Jeffrey A. Miller, Stephen N Mueller and Michael K. Bamat
Clinical Experiment of Mutant Herpes Simplex Virus HF10 Therapy for Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
169-174
Author(s):
A. Nakao, S. Takeda, S. Shimoyama, H. Kasuya, H. Kimata, O. Teshigahara, M. Sawaki, T. Kikumori, Y. Kodera, T. Nagasaka, F. Goshima, Y. Nishiyama and T. Imai
Potentiality of Small Interfering RNAs (siRNA) as Recent Therapeutic Targets for Gene-Silencing
Journal:
Current Drug Targets
Volume:
8
Page:
469-482
Author(s):
Chiranjib Chakraborty
Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
667-679
Author(s):
S. Vannucchi, M. V. Chiantore, G. Mangino, Z. A. Percario, E. Affabris, G. Fiorucci and G. Romeo
Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
687-703
Author(s):
Isabel Varela-Nieto, Markus Hartl, Itziar Gorospe and Yolanda Leon
Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
737-747
Author(s):
Matteo Landriscina, Corrado Spadafora, Mauro Cignarelli and Carlo Barone